South East Asia Steps Up Fight Against TB
South East Asia is gearing for additional momentum in the fight against TB, a disease that caused nearly 800,000 deaths in the region in 2015. Increased budgetary outlays, a regional “Innovation to Implementation” fund and the need for high impact interventions were among the key issues brought up at a recent ministerial meeting in India.
You may also be interested in...
Otsuka, which has been under fire over delayed access to delamanid in India, appears to have allied with Mylan, which has now secured a key clearance for the novel multidrug-resistant TB therapy in the country.
An Indian teenager’s court battle for a new tuberculosis drug that doctors say could save her life has cast a harsh spotlight on the slow rollout of breakthrough medicines to treat the disease in the country, one of the world’s biggest TB hotspots.
India has introduced Janssen's Sirturo, a poster child in the war against multidrug-resistant tuberculosis, through its Revised National Tuberculosis Control Program.